The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations

Pediatric Blood and Cancer

Volumn 56, Issue 5, 2011, Pages 789-793

  Brandow, Amanda M ^a,c   Weisman, Steven J ^b,c   Panepinto, Julie A ^a,c  

^a Section of Pediatric Hematology/Oncology   (United States)

^b Department of Anesthesiology ^*  (United States)

^c Children's Hospital of Wisconsin   (United States)

Author keywords

Children; Pain management; Sickle cell disease

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; GABAPENTIN; HYDROXYUREA; IBUPROFEN; MORPHINE; OXYCODONE; TRAMADOL;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CHILD; CHRONIC PAIN; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MALE; PATIENT REFERRAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SICKLE CELL ANEMIA;

ADOLESCENT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; LONGITUDINAL STUDIES; MALE; PAIN; PAIN CLINICS; PAIN MEASUREMENT; PROGNOSIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES;

EID: 79952147106     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22874     Document Type: Article

References (31)

1. Hoffmann RG. Hematology: Basic Principles and Practice. Philadelphia, PA: Elsevier Churchill Livingstone; 2005.
2. Brandow AM, Brousseau DC, Pajewski NM, et al. Vaso-occlusive painful events in sickle cell disease: Impact on child well-being. Pediatr Blood Cancer 2010; 54: 92-97.
3. Brandow AM, Brousseau DC, Panepinto JA, et al. Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events. Br J Haematol 2009; 144: 782-788.
4. Panepinto JA, Brousseau DC, Hillery CA, et al. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer 2005; 44: 182-186.
5. Smith WR, Penberthy LT, Bovbjerg VE, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med 2008; 148: 94-101.
6. Panepinto JA, Walters MC, Carreras J, et al. Matched-related donor transplantation for sickle cell disease: Report from the Center for International Blood and Transplant Research. Br J Haematol 2007; 137: 479-485.
7. Castellino SM, Combs MR, Zimmerman SA, et al. Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: Frequency, characteristics and significance. Br J Haematol 1999; 104: 189-194.
8. Charache S, Terrin ML, Moore RD, et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 1995; 332: 1317-1322.
9. Benjamin LJ, Jacox DC, Odesina AK, et al. Guideline for the management of acute and chronic pain in sickle cell disease [American Pain Society clinical practice guideline series No 1]. Glenview, IL; 1999. Report.
10. The Management of Sickle Cell Disease. Volume Pub No.02=2117. NIH; 2002. p 161-165.
11. Flor H, Fydrich T, Turk DC. Efficacy of multidisciplinary pain treatment centers: A meta-analytic review. Pain 1992; 49: 221-230.
12. Gil KM, Anthony KK, Carson JW, et al. Daily coping practice predicts treatment effects in children with sickle cell disease. J Pediatr Psychol 2001; 26: 163-173.
13. Gil KM, Carson JW, Sedway JA, et al. Follow-up of coping skills training in adults with sickle cell disease: Analysis of daily pain and coping practice diaries. Health Psychol 2000; 19: 85-90.
14. Chen E, Cole SW, Kato PM. A review of empirically supported psychosocial interventions for pain and adherence outcomes in sickle cell disease. J Pediatr Psychol 2004; 29: 197-209.
15. Cipher DJ, Fernandez E, Clifford AC. cost-effectiveness and health care utilization in a multidisciplinary pain center: Comparison of three treatment groups. J Clin Psychol Med Setting 2001; 8: 237-244.
16. Brousseau DC, Owens PL, Mosso AL, et al. Acute care utilization and rehospitalizations for sickle cell disease. JAMA 2010; 303: 1288-1294.
17. McClish DK, Levenson JL, Penberthy LT, et al. Gender differences in pain and healthcare utilization for adult sickle cell patients: The PiSCES Project. J Women Health (Larchmt) 2006; 15: 146-154.
18. Paller CJ, Campbell CM, Edwards RR, et al. Sex-based differences in pain perception and treatment. Pain Med 2009; 10: 289-299.
19. Fillingim RB, King CD, Ribeiro-Dasilva MC, et al. Sex, gender, and pain: A review of recent clinical and experimental findings. J Pain 2009; 10: 447-485.
20. Paulson PE, Minoshima S, Morrow TJ, et al. Gender differences in pain perception and patterns of cerebral activation during noxious heat stimulation in humans. Pain 1998; 76: 223-229.
21. Chang L, Heitkemper MM. Gender differences in irritable bowel syndrome. Gastroenterology 2002; 123: 1686-1701.
22. Greenspan JD, Craft RM, LeResche L, et al. Studying sex and gender differences in pain and analgesia: A consensus report. Pain 2007; 132: S26-S45.
23. Almeida A, Roberts I. Bone involvement in sickle cell disease. Br J Haematol 2005; 129: 482-490.
24. Ware HE, Brooks AP, Toye R, et al. Sickle cell disease and silent avascular necrosis of the hip. J Bone Joint Surg Br 1991; 73: 947-949.
25. Adekile AD, Gupta R, Yacoub F, et al. Avascular necrosis of the hip in children with sickle cell disease and high Hb F: Magnetic resonance imaging findings and influence of alpha-thalassemia trait. Acta Haematol 2001; 105: 27-31.
26. Schmelzle-Lubiecki BM, Campbell KA, Howard RH, et al. Long-term consequences of early infant injury and trauma upon somatosensory processing. Eur J Pain 2007; 11: 799-809.
27. Curatolo M, Petersen-Felix S, Arendt-Nielsen L, et al. Central hypersensitivity in chronic pain after whiplash injury. Clin J Pain 2001; 17: 306-315.
28. CAU US Preventive Services Task Force. Guide to clinical preventive services: Report of the US Preventive Services Task Force. 2nd edition. Baltimore, MD: US Preventive Services Task Force; 1996 (Report).
29. Gil KM, Williams DA, Thompson RJ, Jr., et al. Sickle cell disease in children and adolescents: The relation of child and parent pain coping strategies to adjustment. J Pediatr Psychol 1991; 16: 643-663.
30. Gil KM, Wilson JJ, Edens JL. The stability of pain coping strategies in young children adolescents, and adults with sickle cell disease over an 18-month period. Clin J Pain 1997; 13: 110-115.
31. Gil KM, Edens JL, Wilson JJ, et al. Coping strategies and laboratory pain in children with sickle cell disease. Ann Behav Med 1997; 19: 22-29.